全文获取类型
收费全文 | 180224篇 |
免费 | 1242篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 1184篇 |
儿科学 | 6727篇 |
妇产科学 | 3018篇 |
基础医学 | 17237篇 |
口腔科学 | 1828篇 |
临床医学 | 12575篇 |
内科学 | 32000篇 |
皮肤病学 | 803篇 |
神经病学 | 16845篇 |
特种医学 | 9086篇 |
外科学 | 29710篇 |
综合类 | 2329篇 |
预防医学 | 18152篇 |
眼科学 | 2802篇 |
药学 | 9683篇 |
中国医学 | 630篇 |
肿瘤学 | 16889篇 |
出版年
2022年 | 59篇 |
2021年 | 102篇 |
2020年 | 53篇 |
2019年 | 85篇 |
2018年 | 22009篇 |
2017年 | 17430篇 |
2016年 | 19596篇 |
2015年 | 998篇 |
2014年 | 913篇 |
2013年 | 904篇 |
2012年 | 7092篇 |
2011年 | 21160篇 |
2010年 | 18914篇 |
2009年 | 11602篇 |
2008年 | 19631篇 |
2007年 | 21874篇 |
2006年 | 737篇 |
2005年 | 2359篇 |
2004年 | 3574篇 |
2003年 | 4514篇 |
2002年 | 2680篇 |
2001年 | 504篇 |
2000年 | 635篇 |
1999年 | 358篇 |
1998年 | 269篇 |
1997年 | 235篇 |
1996年 | 128篇 |
1995年 | 141篇 |
1994年 | 124篇 |
1993年 | 98篇 |
1992年 | 180篇 |
1991年 | 201篇 |
1990年 | 246篇 |
1989年 | 203篇 |
1988年 | 153篇 |
1987年 | 145篇 |
1986年 | 125篇 |
1985年 | 119篇 |
1984年 | 102篇 |
1983年 | 89篇 |
1982年 | 58篇 |
1980年 | 67篇 |
1979年 | 76篇 |
1978年 | 48篇 |
1970年 | 56篇 |
1969年 | 59篇 |
1968年 | 54篇 |
1938年 | 60篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
Jazlyn Read Judith Symmons Jane M. Palmer Grant W. Montgomery Nicholas G. Martin Nicholas K. Hayward 《Familial cancer》2016,15(4):651-663
Familial cancer risk has been proposed as a shared feature of many cancers, and overall susceptibility is influenced by combinations of low to moderate risk polymorphisms, rare high penetrance germline mutations, and modulation of risk by environmental and genetic factors. Clustering of melanoma occurs in approximately 10 % of families, and an over-representation of additional cancers has been noticed in some ‘melanoma’ families. The degree to which other cancers aggregate in families affected by melanoma has not been well defined. Therefore, this study aimed to assess the risk of cancers other than melanoma in a cohort of 178 ‘intermediate risk’ melanoma families, not selected for specific genetic mutations. Families designated as ‘intermediate risk’ had two first degree relatives (FDRs) affected by melanoma when ascertained between 1982 and 1990, and were followed up over a 33 year period to assess new occurrences of cancer. We included 414 melanoma cases and 529 FDRs, comprising 25,264 person years of observation. Standardised incidence ratios and their 95 % confidence intervals were calculated for all invasive cancers, comparing observed to expected cases of cancer based on age and sex specific incidence rates for the Queensland population. Statistically significant increases were found for bladder cancer in females (observed, 7; expected, 1.99; SIR, 3.52; 95 % CI 1.41–7.25), lymphoid leukaemia in females (observed, 6; expected, 1.75; SIR, 3.43; 95 % CI 1.26–7.46), and myeloma in female melanoma cases (observed, 4; expected, 0.82; SIR, 4.89; 95 % CI 1.33–12.52). Over-representation of bladder cancer, lymphoid leukaemia, and myeloma in females of the cohort may suggest sex-dependent co-modifiers, and it is possible that specific combinations of polymorphisms predispose to certain cancer types. 相似文献
984.
Craig Gerrand Nick Athanasou Bernadette Brennan Robert Grimer Ian Judson Bruce Morland David Peake Beatrice Seddon Jeremy Whelan On behalf of the British Sarcoma Group 《Clinical sarcoma research》2016,6(1):7
This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Network and The National Institute for Health and Care Excellence have been incorporated, and the literature since 2010 reviewed. The standards represent a consensus amongst British Sarcoma Group members in 2015. It is acknowledged that these guidelines will need further updates as care evolves. The key recommendations are that bone pain or a palpable mass should always lead to further investigation and that patients with clinico-radiological findings suggestive of a primary bone tumour at any site in the skeleton should be referred to a specialist centre and managed by a fully accredited bone sarcoma multidisciplinary team. Treatment recommendations are provided for the major tumour types and for localised, metastatic and recurrent disease. Follow up schedules are suggested. 相似文献
985.
986.
Martina Zacher Markus V. Heppt Titus J. Brinker Kinan M. Hayani Michael J. Flaig Carola Berking 《Medical oncology (Northwood, London, England)》2018,35(10):135
Sarcomas are a heterogeneous group of mesenchymal tumors which can affect bone and soft tissue. Leiomyosarcoma (LMS) is a rare subtype localized to the skin or subcutaneous tissue. Due to the heterogeneity of sarcomas, reviews and guidelines with an in-depth focus specifically on primary LMS of the skin are sparse. This article is intended to provide an up to date and systematic overview on diagnosis, treatment, and surveillance of this rare entity to provide a framework for decision making and management for dermato-oncologists. We discuss novel treatment options for advanced disease such as targeted therapy with kinase inhibitors and immune checkpoint blockade which may improve the prognosis even in advanced stages of LMS. 相似文献
987.
988.
989.
Kai-Ming Duan Jia-Hui Ma Sai-Ying Wang YingYong Zhou HeYa Yu 《Metabolic brain disease》2018,33(3):647-660
The Postpartum depression (PPD) is the most common postpartum psychiatric disorder, afflicting approximately 10%–20% of new mothers. Clinical symptoms of the PPD include depressive disorder, agitation, insomnia, anxiety and confusion, resulting in an increase in suicidal tendencies, thereby having significant impacts on the puerpera, newborn and their family. A growing body of data indicate a role for alterations in tryptophan metabolism in the PPD. The metabolism of tryptophan produces an array of crucial factors that can differentially regulate key physiological processes linked to the PPD. Importantly, an increase in stress hormones and immune-inflammatory activity drives tryptophan to the production of neuroregulatory kynurenine pathway products and away from the serotonin and melatonin pathways. This links the PPD to other disorders of depressed mood, which are classically associated with decreased serotonin and melatonin, coupled to increases in kynurenine pathway products. Several kynurenine pathway products, such as kynurenic acid and quinolinic acid, can have neuroregulatory effects, with consequences pathological underpinnings of the PPD. The current article reviews the role of alterations in tryptophan metabolism in the PPD. 相似文献
990.